Analyst firms · Barclays · FTRE

Barclays FTRE price target and rating history

Fortrea Holdings Inc. (FTRE) · Health Care

Barclays rates Fortrea Holdings Inc. (FTRE) Overweight with a $23 price target, as of its latest action on Oct 6, 2026. It has published 6 rating actions on FTRE since August 2023, including 3 upgrades and 1 downgrade. Across 8 firms with a FTRE price target in the last 12 months, the median target is $22. Barclays's $23 is 5% above that.

Current rating
Overweight
Price target
$23
Median target, all firms
$22
Actions on FTRE
6

Barclays price target on FTRE

$38$22$6202420252026
Barclays price target on FTRE, each point a stated target, August 2023 to October 2026.

Every Barclays rating on FTRE

How other firms rate FTRE

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
MizuhoUnderperform$19Nov 11, 2026
Deutsche BankBuy$25Oct 15, 2026
BarclaysOverweight$23Oct 6, 2026
UBSNeutral$22Sep 30, 2026
TD CowenBuy$15Mar 9, 2026
Truist SecuritiesBuy$22Jan 8, 2026
Evercore ISIOutperform$25Jan 6, 2026
CitigroupBuy$21Dec 11, 2025

Questions about Barclays and FTRE

What is Barclays's price target for FTRE?
Barclays's latest stated price target for Fortrea Holdings Inc. (FTRE) is $23, from its action on Oct 6, 2026.
What is Barclays's rating on FTRE?
Barclays rates FTRE Overweight, a bullish rating, as of Oct 6, 2026.
When did Barclays last change its view on FTRE?
On Oct 6, 2026, Barclays upgrades to Overweight from Equal Weight, price target $23.
How does Barclays's FTRE target compare with other analysts?
Across 8 firms with a FTRE price target in the last 12 months, the median target is $22. Barclays's $23 is 5% above that.

More FTRE rating histories

All Barclays ratingsFTRE news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.